JCIA
CRMD icon

Jackson Creek Investment Advisors’s CorMedix CRMD Stock Holding History

Jackson Creek Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,060
Closed -$443K – 315
2025
Q4 		$443K Buy
+38,060
New +$421K 0.13% 221

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Jackson Creek Investment Advisors's CRMD Position: Q1 2026 in Review

Jackson Creek Investment Advisors sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 38,060 shares — an estimated $443K sold.

Jackson Creek Investment Advisors first reported a position in CRMD in Q4 2025 and held it in 1 quarter. The position peaked at $443K in Q4 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Jackson Creek Investment Advisors reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 38,060 CorMedix shares in Q1 2026, an estimated $443K.
  • Jackson Creek Investment Advisors first reported a position in CorMedix in Q4 2025 and held it in 1 quarter.
  • Jackson Creek Investment Advisors's CorMedix position peaked at $443K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.